Usa Datta

Title: Innovations of Usa Datta in Procollagen C-Proteinase Inhibitors

Introduction

Usa Datta is an accomplished inventor based in the County of Kent, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as procollagen C-proteinase inhibitors. With a total of 2 patents to his name, Usa Datta is recognized for his innovative approach to addressing medical conditions mediated by procollagen C-proteinase.

Latest Patents

Usa Datta's latest patents include the development of 3-ox(adi)azolylpropanohydroxamic acids, which are useful as procollagen C-proteinase inhibitors. These compounds, defined by specific formulas, are designed to treat conditions that are mediated by procollagen C-proteinase. The patents also cover their salts, solvates, and prodrugs, showcasing the versatility and potential applications of these innovative compounds.

Career Highlights

Usa Datta is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on groundbreaking research and development in the field of biochemistry. His contributions have not only advanced scientific knowledge but also have the potential to improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Usa Datta has collaborated with notable colleagues, including Paul Vincent Fish and Kim James. These collaborations have fostered a productive research environment, leading to significant advancements in their shared field of study.

Conclusion

Usa Datta's innovative work in the development of procollagen C-proteinase inhibitors highlights his commitment to advancing medical science. His contributions at Pfizer Corporation and his patented inventions are paving the way for new treatments that could benefit many patients.